From a chemical pharmacy standpoint, Relafen 750 ( Naproxen Sodium ) presents a fascinating case study in therapeutic action. Its mechanism of effect primarily involves the blockade of cyclooxygenase ( COX enzymes ) enzymes, particularly COX-II , leading to a reduction in the synthesis of inflammatory mediators. This targeted inhibition accounts fo